Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.072 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.02 | 0.7 |